Review of Tecsys Inc.

JUL 16, 2024 - TCS has demonstrated strong organic growth, and it has a healthy balance sheet and a strong backlog. Its recent results came in below expectations, but long-term demand looks healthy, and its updated guidance helped to support the stock price. It trades at a premium valuation to its peers, but we feel its strength lies in its niche healthcare vertical market, and if it can continue to grow its sales pipeline and expand its margins, that its premium valuation can be justified. We are maintaining our rating of ‘B+’.

Download Report

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

TECSYS Inc. (TCS $36.95)
- $36.95 P/E (TTM): 203.33X Cap: $544M
- View TCS Profile
- View Questions on TCS
- View Reports on TCS

Q: Could you please discuss Tcs recent quarterly result.
Do you feel the company is a wise investment going forward?
Did the quarter live up to your expectations?
Thank you

Read Answer Asked by maida on July 01, 2025

Salesforce Inc. (CRM $262.28)
- $262.28 P/E (TTM): 41.06X Cap: $250.73B
- View CRM Profile
- View Questions on CRM
Oracle Corporation (ORCL $243.54)
- $243.54 P/E (TTM): 56.56X Cap: $684.06B
- View ORCL Profile
- View Questions on ORCL
Descartes Systems Group Inc. (The) (DSG $142.56)
- $142.56 P/E (TTM): 63.41X Cap: $12.22B
- View DSG Profile
- View Questions on DSG
- View Reports on DSG
Shopify Inc. Class A Subordinate Voting Shares (SHOP $175.79)
- $175.79 P/E (TTM): 104.34X Cap: $228.06B
- View SHOP Profile
- View Questions on SHOP
- View Reports on SHOP
TECSYS Inc. (TCS $36.95)
- $36.95 P/E (TTM): 203.33X Cap: $544M
- View TCS Profile
- View Questions on TCS
- View Reports on TCS
ServiceNow Inc. (NOW $959.91)
- $959.91 P/E (TTM): 130.72X Cap: $198.70B
- View NOW Profile
- View Questions on NOW
Qualys Inc. (QLYS $139.51)
- $139.51 P/E (TTM): 28.49X Cap: $5.06B
- View QLYS Profile
- View Questions on QLYS
Synopsys Inc. (SNPS $591.46)
- $591.46 P/E (TTM): 68.64X Cap: $91.77B
- View SNPS Profile
- View Questions on SNPS
Galaxy Digital Inc. Class A common stock (GLXY $37.55)
- $37.55 Cap: $13.02B
- View GLXY Profile
- View Questions on GLXY
- View Reports on GLXY

Q: Hi,
In your answer to Neil yesterday, you said that there are numerous high growth software companies that remain down 20%.+ Could you name several you like, both US and Canadian? Thank you Mike.

Read Answer Asked by Mike on May 21, 2025

Alphabet Inc. (GOOG $191.15)
- $191.15 P/E (TTM): 20.75X Cap: $2.31T
- View GOOG Profile
- View Questions on GOOG
Royal Bank of Canada (RY $182.36)
- $182.36 P/E (TTM): 19.69X Cap: $257.04B
- View RY Profile
- View Questions on RY
Tamarack Valley Energy Ltd. (TVE $5.07)
- $5.07 P/E (TTM): 10.79X Cap: $2.56B
- View TVE Profile
- View Questions on TVE
TECSYS Inc. (TCS $36.95)
- $36.95 P/E (TTM): 203.33X Cap: $544M
- View TCS Profile
- View Questions on TCS
- View Reports on TCS
Coveo Solutions Inc. Subordinate voting shares (CVO $8.34)
- $8.34 Cap: $802M
- View CVO Profile
- View Questions on CVO
Brookfield Corporation Class A Limited Voting Shares (BN $90.77)
- $90.77 P/E (TTM): 240.69X Cap: $152.08B
- View BN Profile
- View Questions on BN
Lumine Group Inc. (LMN $51.94)
- $51.94 Cap: $13.82B
- View LMN Profile
- View Questions on LMN
- View Reports on LMN

Q: One of my children (early 20's) has funds in a TFSA they are looking to put in a high risk/high return stock. I'd asked them to do some homework on their own and they've (with some back and forth) come up with 3 names; 2 of which do not register when symbols entered.

Already owned are ASCU (1/2 position), Full positions of BN, LMN, RY, TCS, 1.5x positions of TVE, GOOG and 3x position of NVDA.

Biotech or tech seem to be the preferred themes but are not "must own" if there is something better,

The top 3 names so far are Coveo, Cardiol and Oncolytics Biotech. I would appreciate your thoughts on these 3 options, perhaps place them in order of preference and add 2 you would recommend as a high risk/high reward test.

Great work all....thank you.

Read Answer Asked by Dave on January 30, 2025